In a report released today, Matthew Weston from UBS maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

Broker UBS noted that CBA's earnings per share (EPS) could rise at a compound annual growth rate (CAGR) of between 2.5% to 3% ...

UBS Global Wealth Management has reduced its 2025 target for the S&P 500 by 200 points to 6,400, citing tariff concerns and the “shock” of uncertain White House policies. “Recent economic weakness and ...

UBS Global Wealth Management cut the S&P 500's 2025 target to below the 6,500 mark, widely mirroring actions from other Wall ...

UBS reiterates its Attractive rating on China’s tech sector for its earnings growth prospects but remains cautious of potential setbacks if Sino-US tensions worsen, which could affect US investment ...

Owners of Rio Tinto Ltd (ASX: RIO) shares will want to see what profit their mining company is projected to make in the next ...

Proxy advisory firm Ethos on Thursday urged UBS shareholders to reject the bank's remuneration, share buyback program and ...

Ex-UBS Group AG star trader, Tom Hayes, agreed to manipulate and rig Libor to dishonestly boost profits, prosecution lawyers ...

A £1 billion profit by Next today illuminated an otherwise poor FTSE 100 session as stock market volatility returned on the ...

European stocks are expected to open sharply lower Thursday as global markets react to new automotive tariffs announced by ...

When UBS Chair Colm Kelleher was negotiating the weekend rescue of Credit Suisse in March 2023, the arcane regulatory ...